Valuation Bayer AG Warsaw S.E.

Stocks

Delayed Warsaw S.E. 05:12:41 2026-08-25 EDT			5-day change	1st Jan Change
210.50 ^PLN	+1.84%		-0.96%	+34.29%

03:21am	Bayer Group Receives Approval For Sevabertinib In Japan For HER2-Mutant Non-Small Cell Lung Cancer	CI
08-24	CAC 40 pauses ahead of Nvidia and Jackson Hole

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	46,174	47,476	33,039	18,975	36,360	47,628	-	-
Change	-	2.82%	-30.41%	-42.57%	91.62%	30.99%	-	-
Enterprise Value (EV) ¹	79,140	78,749	67,302	51,329	82,696	77,707	74,527	71,206
Change	-	-0.49%	-14.54%	-23.73%	61.11%	-6.03%	-4.09%	-4.46%
P/E	46.1x	11.5x	-11.2x	-7.43x	-10.1x	20.7x	15.5x	13.4x
PBR	1.4x	1.22x	1x	0.59x	1.4x	1.69x	1.53x	1.4x
PEG	-	0x	0x	0.6x	-0.2x	-0x	0.5x	0.9x
Capitalization / Revenue	1.05x	0.94x	0.69x	0.41x	0.8x	1.04x	1.01x	0.98x
EV / Revenue	1.8x	1.55x	1.41x	1.1x	1.81x	1.7x	1.59x	1.47x
EV / EBITDA	7.08x	5.83x	5.75x	5.07x	8.55x	8.03x	7.24x	6.43x
EV / EBIT	10.8x	8.51x	8.87x	9.44x	16.2x	13.5x	11.5x	10.1x
EV / FCF	31.9x	19x	28.4x	11.2x	24x	-129x	20.8x	17.1x
FCF Yield	3.13%	5.26%	3.52%	8.94%	4.16%	-0.77%	4.81%	5.83%
Dividend per Share ²	2	2.4	0.11	0.11	0.11	0.1569	0.53	0.9835
Rate of return	4.26%	4.97%	0.33%	0.57%	0.3%	0.32%	1.09%	2.03%
EPS ²	1.02	4.22	-2.99	-2.6	-3.68	2.338	3.125	3.613
Distribution rate	196%	56.9%	-3.68%	-4.23%	-2.99%	6.71%	17%	27.2%
Net sales ¹	44,081	50,739	47,637	46,606	45,575	45,748	46,969	48,537
EBITDA ¹	11,179	13,513	11,706	10,123	9,669	9,678	10,300	11,077
EBIT ¹	7,295	9,257	7,589	5,436	5,108	5,735	6,474	7,076
Net income ¹	1,000	4,150	-2,941	-2,552	-3,620	2,132	2,947	3,477
Net Debt ¹	32,966	31,273	34,263	32,354	46,336	30,079	26,899	23,578
Reference price ²	47.00	48.32	33.63	19.31	37.01	48.48	48.48	48.48
Nbr of stocks (in thousands)	982,424	982,424	982,424	982,424	982,424	982,424	-	-
Announcement Date	3/1/22	2/28/23	3/5/24	3/4/25	3/4/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.49x	12.87x	26.08x	0.56%	1,111B
JOHNSON & JOHNSON	30.37x	-	-	1.97%	658B
ABBVIE INC.	33.76x	7.81x	16.23x	2.59%	467B
ROCHE HOLDING AG	20.64x	4.89x	12.12x	2.7%	369B
NOVARTIS AG	22.46x	5.78x	14.33x	2.76%	301B
ASTRAZENECA PLC	21.25x	4.36x	12.44x	2.02%	256B
AMGEN INC.	28.07x	7.23x	12.84x	2.27%	240B
NOVO NORDISK A/S	13.6x	4.83x	10.09x	3.78%	207B
GILEAD SCIENCES, INC.	-44.84x	6.47x	25.28x	2.25%	182B
Average	17.87x	6.78x	16.18x	2.32%	421.22B
Weighted average by Cap.	25.43x	8.47x	18.61x	1.9%